Epitope distribution in ordered and disordered protein regions - Part A. T-cell epitope frequency, affinity and hydropathy

Journal of Immunological Methods

Volumn 406, Issue , 2014, Pages 83-103

  Mitić, Nenad S ^a   Pavlović, Mirjana D ^a   Jandrlić, Davorka R ^a  

^a UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

Disorder prediction; Epitope selection; Hydropathy prediction; T cell epitope prediction

Indexed keywords

AMINO ACID; DISORDERED PROTEIN; EPITOPE; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; ORDERED PROTEIN; PROTEIN; UNCLASSIFIED DRUG;

ALLELE; ANTIGEN PRESENTATION; ARTICLE; BINDING AFFINITY; HYDROPATHY; HYDROPHOBICITY; IMMUNOLOGICAL PROCEDURES; PREDICTION; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN DATABASE; PROTEIN LOCALIZATION; T LYMPHOCYTE;

DISORDER PREDICTION; EPITOPE SELECTION; HYDROPATHY PREDICTION; T-CELL EPITOPE PREDICTION;

ANTIBODY AFFINITY; ANTIGEN PRESENTATION; ANTIGENS, NEOPLASM; BINDING SITES, ANTIBODY; COMPUTATIONAL BIOLOGY; DATABASES, PROTEIN; EPITOPE MAPPING; EPITOPES, T-LYMPHOCYTE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; NEOPLASM PROTEINS; PROTEIN STRUCTURE, TERTIARY;

EID: 84900860532     PISSN: 00221759     EISSN: 18727905     Source Type: Journal    
DOI: 10.1016/j.jim.2014.02.012     Document Type: Article

References (63)

1. Atanackovic D., Altorki N.K., Cao Y., Ritter E., Ferrara C.A., Ritter G., Gnjatic S. Booster vaccination of cancer patients with MAGE-A3 protein reveals long-term immunological memory or tolerance depending on priming. Proc. Natl. Acad. Sci. U. S. A. 2008, 105(5):1650. 10.1073/pnas.0707140104.
2. Bordner A.J. Towards universal structure-based prediction of class II MHC epitopes for diverse allotypes. PLoS One 2010, 5(12):e14383. 10.1371/journal.pone.0014383.
3. Brown S.A., Stambas J., Zhan X., Slobod K.S., Coleclough C., Zirkel A., Hurwitz J.L. Clustering of Th cell epitopes on exposed regions of HIV envelope despite defects in antibody activity. J. Immunol. 2003, 171(8):4140.
4. Brusic V., Bajic V.B., Petrovsky N. Computational methods for prediction of T-cell epitopes - a framework for modelling, testing, and applications. Methods 2004, 34(4):436. 10.1016/j.ymeth.2004.06.006.
5. Carl P.L., Temple B.R., Cohen P.L. Most nuclear systemic autoantigens are extremely disordered proteins: implications for the etiology of systemic autoimmunity. Arthritis Res. Ther. 2005, 7(6):R1360. 10.1186/ar1832.
6. Carmicle S., Steede N.K., Landry S.J. Antigen three-dimensional structure guides the processing and presentation of helper T-cell epitopes. Mol. Immunol. 2007, 44(6):1159. 10.1016/j.molimm.2006.06.014.
7. Cesson V., Rivals J.P., Escher A., Piotet E., Thielemans K., Posevitz V., Romero P. MAGE-A3 and MAGE-A4 specific CD4(+) T cells in head and neck cancer patients: detection of naturally acquired responses and identification of new epitopes. Cancer Immunol. Immunother. 2011, 60(1):23. 10.1007/s00262-010-0916-z.
8. Chaves F.A., Richards K.A., Torelli A., Wedekind J., Sant A.J. Peptide-binding motifs for the I-Ad MHC class II molecule: alternate pH-dependent binding behavior. Biochemistry 2006, 45(20):6426. 10.1021/bi060194g.
9. Chianese-Bullock K.A., Russell H.I., Moller C., Gerhard W., Monaco J.J., Eisenlohr L.C. Antigen processing of two H2-IEd-restricted epitopes is differentially influenced by the structural changes in a viral glycoprotein. J. Immunol. 1998, 161(4):1599.
10. Consogno G., Manici S., Facchinetti V., Bachi A., Hammer J., Conti-Fine B.M., Protti M.P. Identification of immunodominant regions among promiscuous HLA-DR-restricted CD4+ T-cell epitopes on the tumor antigen MAGE-3. Blood 2003, 101(3):1038. 10.1182/blood-2002-03-0933.
11. Dai G., Carmicle S., Steede N.K., Landry S.J. Structural basis for helper T-cell and antibody epitope immunodominance in bacteriophage T4 Hsp10. Role of disordered loops. J. Biol. Chem. 2002, 277(1):161. 10.1074/jbc.M102259200.
12. Dai Y.D., Carayanniotis G., Sercarz E. Antigen processing by autoreactive B cells promotes determinant spreading. Cell. Mol. Immunol. 2005, 2(3):169.
13. Dimitrov I., Flower D.R., Doytchinova I. Improving in silico prediction of epitope vaccine candidates by union and intersection of single predictors. World J. Vaccin. 2011, 01(02):15. 10.4236/wjv.2011.12004.
14. Dosztanyi Z., Csizmok V., Tompa P., Simon I. IUPred: web server for the prediction of intrinsically unstructured regions of proteins based on estimated energy content. Bioinformatics 2005, 21(16):3433. 10.1093/bioinformatics/bti541.
15. Dosztanyi Z., Meszaros B., Simon I. Bioinformatical approaches to characterize intrinsically disordered/unstructured proteins. Brief. Bioinform. 2010, 11(2):225. 10.1093/bib/bbp061.
16. Dunker A.K., Obradovic Z., Romero P., Garner E.C., Brown C.J. Intrinsic protein disorder in complete genomes. Genome Inform. Ser. Workshop Genome Inform. 2000, 11:161.
17. Greenbaum J., Sidney J., Chung J., Brander C., Peters B., Sette A. Functional classification of class II human leukocyte antigen (HLA) molecules reveals seven different supertypes and a surprising degree of repertoire sharing across supertypes. Immunogenetics 2011, 63(6):325. 10.1007/s00251-011-0513-0.
18. Halling-Brown M., Shaban R., Frampton D., Sansom C.E., Davies M., Flower D., Moss D.S. Proteins accessible to immune surveillance show significant T-cell epitope depletion: implications for vaccine design. Mol. Immunol. 2009, 46(13):2699. 10.1016/j.molimm.2009.05.027.
19. Hopp T.P., Woods K.R. Prediction of protein antigenic determinants from amino acid sequences. Proc. Natl. Acad. Sci. U. S. A. 1981, 78(6):3824.
20. Iakoucheva L.M., Brown C.J., Lawson J.D., Obradovic Z., Dunker A.K. Intrinsic disorder in cell-signaling and cancer-associated proteins. J. Mol. Biol. 2002, 323(3):573.
21. Karlin S., Brocchieri L., Trent J., Blaisdell B.E., Mrazek J. Heterogeneity of genome and proteome content in bacteria, archaea, and eukaryotes. Theor. Popul. Biol. 2002, 61(4):367.
22. Kyte J., Doolittle R.F. A simple method for displaying the hydropathic character of a protein. J. Mol. Biol. 1982, 157(1):105.
23. Landry S.J. Local protein instability predictive of helper T-cell epitopes. Immunol. Today 1997, 18(11):527.
24. Landry S.J. Helper T-cell epitope immunodominance associated with structurally stable segments of hen egg lysozyme and HIV gp120. J. Theor. Biol. 2000, 203(3):189. 10.1006/jtbi.1999.1056.
25. Lin H.H., Ray S., Tongchusak S., Reinherz E.L., Brusic V. Evaluation of MHC class I peptide binding prediction servers: applications for vaccine research. BMC Immunol. 2008, 9:8. 10.1186/1471-2172-9-8.
26. Lin H.H., Zhang G.L., Tongchusak S., Reinherz E.L., Brusic V. Evaluation of MHC-II peptide binding prediction servers: applications for vaccine research. BMC Bioinforma. 2008, 9(Suppl. 12):S22. 10.1186/1471-2105-9-S12-S22.
27. Linding R., Jensen L.J., Diella F., Bork P., Gibson T.J., Russell R.B. Protein disorder prediction: implications for structural proteomics. Structure 2003, 11(11):1453.
28. Lobanov M.Y., Galzitskaya O.V. The Ising model for prediction of disordered residues from protein sequence alone. Phys. Biol. 2011, 8(3):035004. 10.1088/1478-3975/8/3/035004.
29. Lund O., Nielsen M., Kesmir C., Petersen A.G., Lundegaard C., Worning P., Brunak S. Definition of supertypes for HLA molecules using clustering of specificity matrices. Immunogenetics 2004, 55(12):797. 10.1007/s00251-004-0647-4.
30. Marturano J., Longhi R., Casorati G., Protti M.P. MAGE-A3(161-175) contains an HLA-DRbeta4 restricted natural epitope poorly formed through indirect presentation by dendritic cells. Cancer Immunol. Immunother. 2008, 57(2):207. 10.1007/s00262-007-0364-6.
31. Marturano J., Longhi R., Russo V., Protti M.P. Endosomal proteases influence the repertoire of MAGE-A3 epitopes recognized in vivo by CD4+ T cells. Cancer Res. 2008, 68(5):1555. 10.1158/0008-5472.CAN-07-5233.
32. Melton S.J., Landry S.J. Three dimensional structure directs T-cell epitope dominance associated with allergy. Clin. Mol. Allergy 2008, 6:9. 10.1186/1476-7961-6-9.
33. Meszaros B., Simon I., Dosztanyi Z. Prediction of protein binding regions in disordered proteins. PLoS Comput. Biol. 2009, 5(5):e1000376. 10.1371/journal.pcbi.1000376.
34. Mirano-Bascos D., Tary-Lehmann M., Landry S.J. Antigen structure influences helper T-cell epitope dominance in the human immune response to HIV envelope glycoprotein gp120. Eur. J. Immunol. 2008, 38(5):1231. 10.1002/eji.200738011.
35. Musson J.A., Walker N., Flick-Smith H., Williamson E.D., Robinson J.H. Differential processing of CD4 T-cell epitopes from the protective antigen of Bacillus anthracis. J. Biol. Chem. 2003, 278(52):52425. 10.1074/jbc.M309034200.
36. Nielsen M., Lundegaard C., Blicher T., Lamberth K., Harndahl M., Justesen S., Buus S. NetMHCpan, a method for quantitative predictions of peptide binding to any HLA-A and -B locus protein of known sequence. PLoS One 2007, 2(8):e796. 10.1371/journal.pone.0000796.
37. Nielsen M., Lundegaard C., Blicher T., Peters B., Sette A., Justesen S., Lund O. Quantitative predictions of peptide binding to any HLA-DR molecule of known sequence: NetMHCIIpan. PLoS Comput. Biol. 2008, 4(7):e1000107. 10.1371/journal.pcbi.1000107.
38. Noivirt-Brik O., Prilusky J., Sussman J.L. Assessment of disorder predictions in CASP8. Proteins 2009, 77(Suppl. 9):210. 10.1002/prot.22586.
39. Patronov A., Doytchinova I. T-cell epitope vaccine design by immunoinformatics. Open Biol. 2013, 3(1):120139. 10.1098/rsob.120139.
40. Radivojac P., Iakoucheva L.M., Oldfield C.J., Obradovic Z., Uversky V.N., Dunker A.K. Intrinsic disorder and functional proteomics. Biophys. J. 2007, 92(5):1439. 10.1529/biophysj.106.094045.
41. Rajagopalan K., Mooney S.M., Parekh N., Getzenberg R.H., Kulkarni P. A majority of the cancer/testis antigens are intrinsically disordered proteins. J. Cell. Biochem. 2011, 112(11):3256. 10.1002/jcb.23252.
42. Rathi B., Sarangi A., Naik S. Knowledge based threading approach to model the MHC-binders to MHC class I alleles in Hepatitis E Virus: a clue for epitope-based vaccine design. Internet J. Med. Inform. 2010, 5(2). 10.5580/22cf.
43. Reche P.A., Reinherz E.L. PEPVAC: a web server for multi-epitope vaccine development based on the prediction of supertypic MHC ligands. Nucleic Acids Res. 2005, 33(Web Server issue):W138. 10.1093/nar/gki357.
44. Renkvist N., Castelli C., Robbins P.F., Parmiani G. A listing of human tumor antigens recognized by T cells. Cancer Immunol. Immunother. 2001, 50(1):3-15.
45. Sant A.J., Chaves F.A., Jenks S.A., Richards K.A., Menges P., Weaver J.M., Lazarski C.A. The relationship between immunodominance, DM editing, and the kinetic stability of MHC class II:peptide complexes. Immunol. Rev. 2005, 207:261. 10.1111/j.0105-2896.2005.00307.x.
46. Scanlan M.J., Gure A.O., Jungbluth A.A., Old L.J., Chen Y.T. Cancer/testis antigens: an expanding family of targets for cancer immunotherapy. Immunol. Rev. 2002, 188:22.
47. Schlessinger A., Punta M., Yachdav G., Kajan L., Rost B. Improved disorder prediction by combination of orthogonal approaches. PLoS One 2009, 4(2):e4433. 10.1371/journal.pone.0004433.
48. Seong S.Y., Matzinger P. Hydrophobicity: an ancient damage-associated molecular pattern that initiates innate immune responses. Nat. Rev. Immunol. 2004, 4(6):469. 10.1038/nri1372.
49. Sette A., Fikes J. Epitope-based vaccines: an update on epitope identification, vaccine design and delivery. Curr. Opin. Immunol. 2003, 15(4):461.
50. Sidney J., Peters B., Frahm N., Brander C., Sette A. HLA class I supertypes: a revised and updated classification. BMC Immunol. 2008, 9:1. 10.1186/1471-2172-9-1.
51. Southwood S., Sidney J., Kondo A., del Guercio M.-F., Appella E., Hoffman S., Kubo R.T., Chesnut R.W., Grey H.M., Sette A. Several common HLA-DR types share largely overlapping peptide binding repertoires. J. Immunol. 1998, 160:3363.
52. Straetemans T., van Brakel M., van Steenbergen S., Broertjes M., Drexhage J., Hegmans J., Debets R. TCR gene transfer: MAGE-C2/HLA-A2 and MAGE-A3/HLA-DP4 epitopes as melanoma-specific immune targets. Clin. Dev. Immunol. 2012, 2012:586314. 10.1155/2012/586314.
53. Suskiewicz M.J., Sussman J.L., Silman I., Shaul Y. Context-dependent resistance to proteolysis of intrinsically disordered proteins. Protein Sci. 2011, 20(8):1285. 10.1002/pro.657.
54. Tompa P. Structure and Function of Intrinsically Disordered Proteins 2009, Chapman and Hall/CRC, (ISBN: 9871420078923).
55. Uversky V.N. The mysterious unfoldome: structureless, underappreciated, yet vital part of any given proteome. J. Biomed. Biotechnol. 2010, 2010:568068. 10.1155/2010/568068.
56. Uversky V.N. Intrinsically disordered proteins may escape unwanted interactions via functional misfolding. Biochim. Biophys. Acta 2011, 1814(5):693.
57. Uversky V.N., Dunker A.K. Understanding protein non-folding. Biochim. Biophys. Acta 2010, 1804(6):1231. 10.1016/j.bbapap.2010.01.017.
58. Uversky V.N., Gillespie J.R., Fink A.L. Why are "natively unfolded" proteins unstructured under physiologic conditions?. Proteins 2000, 41(3):415.
59. Vucetic S., Brown C.J., Dunker A.K., Obradovic Z. Flavors of protein disorder. Proteins 2003, 52(4):573. 10.1002/prot.10437.
60. Weaver J.M., Sant A.J. Understanding the focused CD4 T cell response to antigen and pathogenic organisms. Immunol. Res. 2009, 45(2-3):123. 10.1007/s12026-009-8095-8.
61. Weaver J.M., Lazarski C.A., Richards K.A., Chaves F.A., Jenks S.A., Menges P.R., Sant A.J. Immunodominance of CD4 T cells to foreign antigens is peptide intrinsic and independent of molecular context: implications for vaccine design. J. Immunol. 2008, 181(5):3039.
62. Yang X., Yu X. An introduction to epitope prediction methods and software. Rev. Med. Virol. 2009, 19(2):77. 10.1002/rmv.602.
63. Zhang G.L., DeLuca D.S., Keskin D.B., Chitkushev L., Zlateva T., Lund O., Brusic V. MULTIPRED2: a computational system for large-scale identification of peptides predicted to bind to HLA supertypes and alleles. J. Immunol. Methods 2011, 374(1-2):53. 10.1016/j.jim.2010.11.009.